GR3020436T3 - Transdermal system - Google Patents
Transdermal systemInfo
- Publication number
- GR3020436T3 GR3020436T3 GR960401809T GR960401809T GR3020436T3 GR 3020436 T3 GR3020436 T3 GR 3020436T3 GR 960401809 T GR960401809 T GR 960401809T GR 960401809 T GR960401809 T GR 960401809T GR 3020436 T3 GR3020436 T3 GR 3020436T3
- Authority
- GR
- Greece
- Prior art keywords
- transdermal system
- active substance
- dissociation
- controlled
- transdermal
- Prior art date
Links
- 229940100640 transdermal system Drugs 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000010494 dissociation reaction Methods 0.000 abstract 1
- 230000005593 dissociations Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nanotechnology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Studio Devices (AREA)
- Exposure Control For Cameras (AREA)
- Details Of Cameras Including Film Mechanisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8904296A SE8904296D0 (sv) | 1989-12-21 | 1989-12-21 | Transdermal system |
| PCT/SE1990/000822 WO1991009592A1 (en) | 1989-12-21 | 1990-12-12 | Transdermal system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3020436T3 true GR3020436T3 (en) | 1996-10-31 |
Family
ID=20377820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR960401809T GR3020436T3 (en) | 1989-12-21 | 1996-07-02 | Transdermal system |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5120546A (el) |
| EP (1) | EP0519926B1 (el) |
| JP (1) | JP3141110B2 (el) |
| AT (1) | ATE137405T1 (el) |
| AU (1) | AU6973591A (el) |
| DE (1) | DE69026837T2 (el) |
| DK (1) | DK0519926T3 (el) |
| ES (1) | ES2086529T3 (el) |
| GR (1) | GR3020436T3 (el) |
| SE (1) | SE8904296D0 (el) |
| WO (1) | WO1991009592A1 (el) |
Families Citing this family (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3910543A1 (de) * | 1989-04-01 | 1990-10-11 | Lohmann Therapie Syst Lts | Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung |
| US5512306A (en) * | 1992-06-19 | 1996-04-30 | Pharmica Ab | Smoking substitute |
| HU212730B (en) * | 1990-03-28 | 1996-10-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing inclusion complexes of cyclodextrine or its derivative and 3-morpholino-sydnonimine or its salt or its tautomer and pharmaceutical compositions containing them |
| HU210921B (en) * | 1990-03-28 | 1995-09-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them |
| WO1993008825A1 (en) * | 1991-11-04 | 1993-05-13 | Zymogenetics, Inc. | Pdgf gel formulation |
| US5324718A (en) * | 1992-07-14 | 1994-06-28 | Thorsteinn Loftsson | Cyclodextrin/drug complexation |
| US5472954A (en) * | 1992-07-14 | 1995-12-05 | Cyclops H.F. | Cyclodextrin complexation |
| DE4309830C1 (de) * | 1993-03-26 | 1994-05-05 | Lohmann Therapie Syst Lts | Wirkstoffpflaster für die Abgabe von Estradiol an die Haut |
| SE9301171D0 (sv) * | 1993-04-07 | 1993-04-07 | Ab Astra | Pharmaceutical composition containing lipophilic drugs |
| US5750140A (en) * | 1994-05-20 | 1998-05-12 | Novo Nordisk A/S | Transdermal delivery of tiagabine |
| GB2290964A (en) * | 1994-07-08 | 1996-01-17 | Arto Olavi Urtti | Transdermal drug delivery system |
| US5891461A (en) * | 1995-09-14 | 1999-04-06 | Cygnus, Inc. | Transdermal administration of olanzapine |
| US5807570A (en) * | 1995-09-29 | 1998-09-15 | Cygnus, Inc. | Transdermal administration of ropinirole and analogs thereof |
| US5733269A (en) * | 1996-03-15 | 1998-03-31 | Fuisz Technologies Ltd. | Method and kit for positioning transdermal delivery system |
| IT1283102B1 (it) * | 1996-06-06 | 1998-04-07 | Permatec Nv | Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele |
| WO1998017263A1 (en) * | 1996-10-25 | 1998-04-30 | Copley Pharmaceutical Inc. | Transdermal patch |
| US6022558A (en) * | 1997-07-01 | 2000-02-08 | Hu; Oliver Yoa-Pu | Transdermal preparations of oxicams |
| US6630168B1 (en) * | 1997-02-20 | 2003-10-07 | Biomedicines, Inc. | Gel delivery vehicles for anticellular proliferative agents |
| US7150881B2 (en) * | 1997-06-26 | 2006-12-19 | Mylan Technologies, Inc. | Adhesive mixture for transdermal delivery of highly plasticizing drugs |
| IT1294748B1 (it) | 1997-09-17 | 1999-04-12 | Permatec Tech Ag | Formulazione per un dispositivo transdermico |
| US6146656A (en) * | 1998-01-22 | 2000-11-14 | Nitto Denko Corporation | Percutaneous absorption preparation |
| DE19810951B4 (de) * | 1998-03-13 | 2005-09-29 | Ciba Speciality Chemicals Holding Inc. | Verwendung eines textilen Materials als transdermales Abgabesystem sowie Verfahren zu seiner Herstellung |
| AR018321A1 (es) * | 1998-03-26 | 2001-11-14 | Alza Corp | Una forma de dosificacion de liberacion prolongada que comprende oxibutinina y los usos de la oxibutinina y de la forma de dosificacion de liberacionprolongada. |
| US6193996B1 (en) | 1998-04-02 | 2001-02-27 | 3M Innovative Properties Company | Device for the transdermal delivery of diclofenac |
| WO2000019978A2 (en) * | 1998-10-05 | 2000-04-13 | The Penn State Research Foundation | Compositions and methods for enhancing receptor-mediated cellular internalization |
| PT1140039E (pt) | 1998-12-18 | 2010-02-03 | Alza Corp | Dispositivos transparentes de administração transdérmica de nicotina |
| US6248760B1 (en) * | 1999-04-14 | 2001-06-19 | Paul C Wilhelmsen | Tablet giving rapid release of nicotine for transmucosal administration |
| AU5325000A (en) * | 1999-06-05 | 2000-12-28 | David Houze | Solubility enhancement of drugs in transdermal drug delivery systems and methodsof use |
| US6479467B1 (en) * | 1999-12-16 | 2002-11-12 | Eastman Chemical Company | Cyclodextrin ethers |
| DE10003767A1 (de) * | 2000-01-28 | 2001-10-04 | Beiersdorf Ag | Hautfreundliches Wirkstoffpflaster zur transdermalen Verabreichung nichtsteroidaler Antirheumatika |
| KR20030003769A (ko) * | 2000-05-31 | 2003-01-10 | 니찌방 가부시기가이샤 | 경피흡수형 스테로이드 외용제 |
| US6682757B1 (en) | 2000-11-16 | 2004-01-27 | Euro-Celtique, S.A. | Titratable dosage transdermal delivery system |
| IT1319665B1 (it) * | 2000-11-17 | 2003-10-23 | Pharma Biotech Ltd | Addotti di corticosteroidi con polimeri polisaccaridici naturali. |
| US20030206945A1 (en) * | 2000-12-20 | 2003-11-06 | Giulio Tarro | Sticking plaster for controlled release of natural interferon |
| DE10141651B4 (de) * | 2001-08-24 | 2007-02-15 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung |
| US6743254B2 (en) * | 2002-02-01 | 2004-06-01 | Mentor Corporation | Tissue expander with protection against accidental puncture |
| DE10212864B4 (de) * | 2002-03-22 | 2005-12-22 | Beiersdorf Ag | Polymermatrizes umfassend ein Mischsystem zur Löslichkeitsvermittlung von pharmazeutischen Wirkstoffen, Verfahren zu deren Herstellung und deren Verwendung |
| US20040120995A1 (en) * | 2002-04-01 | 2004-06-24 | Martin Debra A | Transdermal delivery of pergolide |
| WO2003092704A1 (fr) * | 2002-04-30 | 2003-11-13 | Mochida Pharmaceutical Co., Ltd. | Preparation externe de vidarabine a propriete systemique amelioree |
| US20030215487A1 (en) * | 2002-05-17 | 2003-11-20 | Il Yang Pharm Co., Ltd. Republic Of Korea | Matrix-type device for the transdermal delivery of testosterone applied to the non-scrotal skin |
| WO2004003145A2 (en) * | 2002-06-28 | 2004-01-08 | Nastech Pharmaceutical Company Inc. | Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| IL152575A (en) * | 2002-10-31 | 2008-12-29 | Transpharma Medical Ltd | A skin-to-skin transmission system of water-insoluble drugs |
| DE10304988A1 (de) * | 2003-02-07 | 2004-09-09 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System mit verbessertem Hautklebeverhalten |
| NZ542969A (en) * | 2003-04-30 | 2009-09-25 | Purdue Pharma Lp | Tamper resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer |
| US8790689B2 (en) | 2003-04-30 | 2014-07-29 | Purdue Pharma L.P. | Tamper resistant transdermal dosage form |
| EP1651197A1 (en) * | 2003-07-28 | 2006-05-03 | ALZA Corporation | Transdermal warfarin-containing delivery system |
| JP4160474B2 (ja) * | 2003-08-01 | 2008-10-01 | リンテック株式会社 | 角質改善用積層シート |
| AU2004287412A1 (en) * | 2003-10-28 | 2005-05-19 | Alza Corporation | Method and apparatus for reducing the incidence of tobacco use |
| DE10357321A1 (de) * | 2003-12-05 | 2005-07-21 | Tesa Ag | Hochtackige Klebmasse, Verfahren zu deren Herstellung und deren Verwendung |
| RU2334507C2 (ru) * | 2004-03-19 | 2008-09-27 | Макнейл Аб | Средство для чрескожного введения никотина |
| WO2007016419A2 (en) * | 2005-07-29 | 2007-02-08 | The General Hospital Corporation | Methods and compositions for reducing skin damage |
| FI118537B (fi) * | 2006-03-08 | 2007-12-14 | Kuopion Yliopisto | Menetelmä syklodekstriinin kompleksoitumisen lisäämiseksi |
| DE102006019293A1 (de) * | 2006-04-21 | 2007-10-25 | LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH | Pflaster, enthaltend ein Fentanyl Analogum |
| US20080156821A1 (en) * | 2006-04-25 | 2008-07-03 | Bradley Stuart Galer | Topical preparation dispensers and methods of using the same |
| US20070248656A1 (en) * | 2006-04-25 | 2007-10-25 | Galer Bradley S | Topical preparation dispensers and methods of using the same |
| US20070254858A1 (en) * | 2006-04-27 | 2007-11-01 | Cronk Peter J | Contraceptive and Acne Medication Combination and Treatment of Acne and Other Diseases with Reduced Side Effects |
| US20070254025A1 (en) * | 2006-04-27 | 2007-11-01 | Cronk Peter J | Oral contraceptive and acne medication combination and treatment of acne with reduced side effects |
| US8158609B1 (en) | 2006-11-02 | 2012-04-17 | Novartis Ag | Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen |
| RU2009127890A (ru) * | 2007-01-17 | 2011-02-27 | Девирэкс Аг (Ch) | Составы, содержащие циклодекстрины |
| DE102007020799A1 (de) | 2007-05-03 | 2008-11-06 | Novosis Ag | Transdermales therapeutisches System mit Remifentanil |
| IE20080661A1 (en) * | 2008-08-11 | 2010-03-03 | Bk Pharma Systems Ltd | Formulations for a two-phase management of wound healing and dressings incorporating such formulations. |
| KR101563308B1 (ko) * | 2008-11-11 | 2015-10-26 | 씨에스피씨 종콰이 팔마씨우티컬 테크놀로지 (스자좡) 컴퍼니 리미티드 | 피노셈브린과 사이클로덱스트린 또는 그의 유도체와의 포접 화합물 |
| WO2011066471A1 (en) * | 2009-11-25 | 2011-06-03 | Loma Linda University Medical Center | Chitosan-based hemostatic textile |
| AR081364A1 (es) * | 2010-05-05 | 2012-08-29 | Glaxo Wellcome Mfg Pte Ltd | Composiciones farmaceuticas de pazopanib y metodos para su elaboracion |
| JP5696279B2 (ja) * | 2010-12-01 | 2015-04-08 | 学校法人自治医科大学 | 長期徐放型薬剤硬膜外腔留置システム |
| US9259357B2 (en) | 2014-04-16 | 2016-02-16 | Loma Linda University | Composition, preparation, and use of chitosan shards for biomedical applications |
| US10653690B1 (en) | 2019-07-09 | 2020-05-19 | Orexo Ab | Pharmaceutical composition for nasal delivery |
| US10729687B1 (en) | 2019-07-09 | 2020-08-04 | Orexo Ab | Pharmaceutical composition for nasal delivery |
| DE102020111668A1 (de) | 2020-04-29 | 2021-11-04 | Organoid Technologies Gmbh | Naturstoffpad |
| BR112022023307A2 (pt) | 2020-05-18 | 2022-12-20 | Orexo Ab | Composição farmacêutica para entrega de fármacos |
| CA3238850A1 (en) | 2021-11-25 | 2023-06-01 | Jonas Savmarker | Pharmaceutical composition comprising adrenaline |
| GB202117016D0 (en) | 2021-11-25 | 2022-01-12 | Orexo Ab | New pharmaceutical device |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56123912A (en) * | 1980-03-05 | 1981-09-29 | Nitto Electric Ind Co Ltd | Drug-containing tape preparation |
| US4661105A (en) * | 1981-06-29 | 1987-04-28 | Alza Corporation | Medical bandage for administering vasodilator drug |
| US4383992A (en) * | 1982-02-08 | 1983-05-17 | Lipari John M | Water-soluble steroid compounds |
| US4596795A (en) * | 1984-04-25 | 1986-06-24 | The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services | Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives |
| EP0241806A1 (en) * | 1986-04-14 | 1987-10-21 | Fujisawa Pharmaceutical Co., Ltd. | Sustained-release transdermal delivery preparations |
| JPH0819004B2 (ja) * | 1986-12-26 | 1996-02-28 | 日清製粉株式会社 | 徐放性医薬製剤 |
| ZA885069B (en) * | 1987-07-24 | 1989-03-29 | Fujisawa Pharmaceutical Co | Sustained-release percutaneous preparations |
| US4774329A (en) * | 1987-08-04 | 1988-09-27 | American Maize-Products Company | Controlled release agent for cetylpyridinium chloride |
| JPH06253662A (ja) * | 1993-02-26 | 1994-09-13 | Iseki & Co Ltd | 脱穀装置 |
-
1989
- 1989-12-21 SE SE8904296A patent/SE8904296D0/xx unknown
-
1990
- 1990-03-07 US US07/490,088 patent/US5120546A/en not_active Expired - Lifetime
- 1990-12-12 ES ES91901412T patent/ES2086529T3/es not_active Expired - Lifetime
- 1990-12-12 DE DE69026837T patent/DE69026837T2/de not_active Expired - Fee Related
- 1990-12-12 EP EP91901412A patent/EP0519926B1/en not_active Expired - Lifetime
- 1990-12-12 DK DK91901412.6T patent/DK0519926T3/da active
- 1990-12-12 JP JP03501897A patent/JP3141110B2/ja not_active Expired - Fee Related
- 1990-12-12 WO PCT/SE1990/000822 patent/WO1991009592A1/en not_active Ceased
- 1990-12-12 AU AU69735/91A patent/AU6973591A/en not_active Abandoned
- 1990-12-12 AT AT91901412T patent/ATE137405T1/de not_active IP Right Cessation
-
1996
- 1996-07-02 GR GR960401809T patent/GR3020436T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69026837D1 (de) | 1996-06-05 |
| AU6973591A (en) | 1991-07-24 |
| ES2086529T3 (es) | 1996-07-01 |
| DE69026837T2 (de) | 1997-01-02 |
| EP0519926B1 (en) | 1996-05-01 |
| JP3141110B2 (ja) | 2001-03-05 |
| WO1991009592A1 (en) | 1991-07-11 |
| EP0519926A1 (en) | 1992-12-30 |
| SE8904296D0 (sv) | 1989-12-21 |
| US5120546A (en) | 1992-06-09 |
| ATE137405T1 (de) | 1996-05-15 |
| JPH05504895A (ja) | 1993-07-29 |
| DK0519926T3 (da) | 1996-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3020436T3 (en) | Transdermal system | |
| GR3035089T3 (en) | Analogs of pth. | |
| AR241008A1 (es) | Procedimiento para el montaje de un ascensor y el ascensor obtenido por el mismo'' | |
| IL92966A0 (en) | Dispensing devices powered by hydrogel | |
| EP0935415A4 (en) | METHOD FOR MAKING CONNECTIONS INTO A CELL | |
| EP0428038A3 (en) | Transdermal application of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol | |
| AU629777B2 (en) | Blocking agents of edrf effect or formation for the treatment of shock | |
| NL300007I1 (nl) | Preparaat voor de gereguleerde afgifte van een werkzame stof. | |
| TW245720B (el) | ||
| HUT53779A (en) | Insecticide preparations containing phenyl-substituted heterocyclic compounds as agents and method for producing the agents | |
| EP0630383A4 (en) | METHODS FOR TREATING DIABETIS. | |
| EP0597329A3 (de) | Verfahren zur Herstellung von alpha-Fluor -beta-dicarbonylverbindungen. | |
| CA2094424A1 (en) | Method of treating osteoporosis with 1.alpha.,24(r)-dihydroxy-22(e)-dehydro-vitamin d3 | |
| IE822012L (en) | Insecticide against aphids | |
| PH22416A (en) | Method of improving the resorption of injected antibacterially active substances or combination | |
| GR3032175T3 (en) | IMPROVED SYSTEM FOR THE TRANSDERMAL APPLICATION OF PHARMACOLOGICALLY ACTIVE COMPOUNDS AT CONTROLLED pH. | |
| HU902102D0 (en) | Pesticides containing n-amino-1,2,4-triazine derivate as active agent and process for producing the active substance | |
| MW2287A1 (en) | Insecticidal agent based on the active compound endosulfan | |
| FR2696085B1 (fr) | Housse en tissu pour siège, notamment automobile. | |
| EP0114389A3 (en) | Substituted arylglyoxal derivatives | |
| EP0448726A4 (en) | 2-substituted 2-cyclopentenone and carcinostatic agent and osteogenesis promoter containing the same as active ingredient | |
| EP0183922A3 (en) | Process and agent for combating the rhomboid looper boarmia rhomboidaria | |
| EP0297140A4 (en) | COATING AGENT FOR COATED SURFACES. | |
| ITRM920002A0 (it) | Procedimento per il trattamento disinquinante, di residui contenenti caprolattame. | |
| AR244040A1 (es) | Composiciones insecticidas que contienen amitraz |